Brian Koopman compensation by year
UTAH MEDICAL PRODUCTS Summary Compensation Table · all 8 fiscal years held| Component | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Salary | $103,141 | $107,694 | $111,045 | $113,391 | $120,269 | $131,830 | $140,072 | $153,247 |
| Bonus | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Option awards | $0 | $0 | $0 | $0 | $25,341 | $12,543 | $9,887 | $8,368 |
| Non-equity incentive | $13,814 | $13,276 | $8,970 | $15,014 | $16,377 | $16,377 | $13,579 | $12,009 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $3,388 | $3,516 | $3,484 | $3,437 | $4,412 | $4,569 | $4,255 | $5,453 |
| Total | $120,343 | $124,486 | $123,499 | $131,842 | $166,399 | $165,319 | $167,793 | $179,077 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: UTAH MEDICAL PRODUCTS INC DEF 14A filed April 2, 2026, accession 0001096906-26-000477, and prior-year filings. Open the filing on EDGAR.
How this page was built: the UTAH MEDICAL PRODUCTS INC filed document, accession 0001096906-26-000477. Every figure is read from that document and cited to the page and table it appears in. Filed April 2, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 187 | — | $82.60 |
| Option | 219 | — | $77.07 |
| Option | 344 | — | $64.09 |
| Option | 500 | — | $58.10 |
Per the Outstanding Equity Awards at Fiscal Year-End table in UTAH MEDICAL PRODUCTS INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
UTAH MEDICAL PRODUCTS’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Kevin Cornwell | Chairman & CEO | $341,709 |
| Brian Koopman · this page | Principal Financial Officer | $179,077 |
Brian Koopman's compensation dossier, UTAH MEDICAL PRODUCTS
You have read Brian Koopman's totals and holdings. The dossier adds each equity grant UTAH MEDICAL PRODUCTS disclosed for Brian Koopman and UTAH MEDICAL PRODUCTS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full UTAH MEDICAL PRODUCTS compensation record
free company briefThis page is one person within UTAH MEDICAL PRODUCTS's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order UTAH MEDICAL PRODUCTS's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are UTAH MEDICAL PRODUCTS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order UTMD
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.